These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20640786)
1. Computer assisted design of second-generation colchicine derivatives. Huzil JT; Mane J; Tuszynski JA Interdiscip Sci; 2010 Jun; 2(2):169-74. PubMed ID: 20640786 [TBL] [Abstract][Full Text] [Related]
2. Computational design and biological testing of highly cytotoxic colchicine ring A modifications. Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852 [TBL] [Abstract][Full Text] [Related]
3. Electrostatic contributions to colchicine binding within tubulin isotypes. Huzil JT; Barakat K; Tuszynski JA Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626 [TBL] [Abstract][Full Text] [Related]
4. Free energy calculations on the binding of colchicine and its derivatives with the alpha/beta-tubulin isoforms. Mane JY; Klobukowski M; Huzil JT; Tuszynski J J Chem Inf Model; 2008 Sep; 48(9):1824-32. PubMed ID: 18712858 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors. Zhang X; Kong Y; Zhang J; Su M; Zhou Y; Zang Y; Li J; Chen Y; Fang Y; Zhang X; Lu W Eur J Med Chem; 2015 May; 95():127-35. PubMed ID: 25805446 [TBL] [Abstract][Full Text] [Related]
6. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin. Bhattacharyya B; Panda D; Gupta S; Banerjee M Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966 [TBL] [Abstract][Full Text] [Related]
7. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening. Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059 [TBL] [Abstract][Full Text] [Related]
8. Tubulin structure-based drug design for the development of novel 4β-sulfur-substituted podophyllum tubulin inhibitors with anti-tumor activity. Zhao W; Bai JK; Li HM; Chen T; Tang YJ Sci Rep; 2015 May; 5():10172. PubMed ID: 25959922 [TBL] [Abstract][Full Text] [Related]
9. Naphthylphenstatins as tubulin ligands: synthesis and biological evaluation. Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M Bioorg Med Chem; 2008 Oct; 16(19):8999-9008. PubMed ID: 18790642 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, antiproliferative activity and molecular docking of Colchicine derivatives. Huczyński A; Majcher U; Maj E; Wietrzyk J; Janczak J; Moshari M; Tuszynski JA; Bartl F Bioorg Chem; 2016 Feb; 64():103-12. PubMed ID: 26794327 [TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives. Tseng CY; Mane JY; Winter P; Johnson L; Huzil T; Izbicka E; Luduena RF; Tuszynski JA Mol Cancer; 2010 May; 9():131. PubMed ID: 20509970 [TBL] [Abstract][Full Text] [Related]
12. Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization. Ma Y; Fang S; Li H; Han C; Lu Y; Zhao Y; Liu Y; Zhao C Chem Biol Drug Des; 2013 Jul; 82(1):12-21. PubMed ID: 23786349 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel antitubulin agents by using a virtual screening approach based on a 7-point pharmacophore model of the tubulin colchi-site. Massarotti A; Theeramunkong S; Mesenzani O; Caldarelli A; Genazzani AA; Tron GC Chem Biol Drug Des; 2011 Dec; 78(6):913-22. PubMed ID: 22039890 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of N-phenyl-N'-(2-chloroethyl)ureas in the colchicine-binding site at the interface between alpha- and beta-tubulin. Fortin S; Wei L; Moreau E; Labrie P; Petitclerc E; Kotra LP; C-Gaudreault R Bioorg Med Chem; 2009 May; 17(10):3690-7. PubMed ID: 19398206 [TBL] [Abstract][Full Text] [Related]